Post 200: Top D.C.-Area Businesses

Gene Logic Inc. / GLGC

About Gene Logic Inc.

610 Professional Dr., Gaithersburg, Md. 20879
www.genelogic.com | 301-987-1700 | Founded: 1994

Industry: Biotechnology | Category: Top 100 Companies

Companies selling genetic information have come and gone in the past decade, but Gene Logic — never subject to the same Wall Street hype and the soaring stock prices of its competitors — has persevered with largely the same long-range plan. It compiles a massive database of information on what goes wrong genetically to cause diseases and how those ailments might be cured.
The company hit a milestone in 2005 when the business of selling access to that database and related information, began to turn a profit. "It's the culmination of a lot of work that we've stuck with," said Mark D. Gessler, president and chief executive. "Other groups abandoned this area."
The company still isn't profitable overall, in part because it is investing in new lines of business. But its customer list includes some of the world's biggest drug companies, and Gessler contends that Gene Logic is positioned to benefit as those companies look for more outside help improving the productivity of their vast research programs.
The company is fired up about its new business idea. It is going to big companies to ask for access to drugs that appeared safe in human tests but didn't work, then will run them through animal tests to see if they might be useful in treating other diseases.
Drugs that don't work for one disease sometimes work for another: Viagra, for example, was a failed heart treatment that turned out to work for impotence. But rarely have companies set up systematic programs to find drugs this way, which is what Gene Logic plans to do. "The basic question is: What about those drugs that never made it to the market?" Gessler said.

CFO: Philip L. Rohrer Jr.

2007 Financial Data

Total employees: 430 | Local employees: 400

Company Leadership

Did You Know

Gene Logic sells genetic and biological information to bigger companies to help them find treatments for disease. The company recently launched a business that will try to salvage drugs that didn't work in human tests by finding new uses for them.

© The Washington Post Company